Doctronic

Doctronic

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.doctronic.ai

Last Round

Series B

Mar 24, 2026

Total Funding Raised

$65M

Momentum Score

100 /100

Company Overview

Doctronic is an AI-native healthcare platform based in New York City, founded in 2023 by Dr. Adam Oskowitz and Matt Pavelle. The company provides an "AI doctor" that offers personalized, anonymous health guidance and symptom checking 24/7. For users requiring further care, the platform facilitates video visits with licensed physicians for diagnosis, prescriptions, and referrals. Doctronic aims to make healthcare more accessible, affordable, and efficient by reducing wait times and providing immediate information. The company serves individual consumers as well as enterprise clients like TPAs, payers, hospitals, and employers. It has raised a Seed round and a Series A round from investors including Lightspeed Venture Partners, Union Square Ventures, and Tusk Venture Partners.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Medical AI, NLP & Conversational AI, Patient Engagement, EHR & EMR

Business Model

B2C

Customer Profile

Freemium, Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

AI doctorAI health assistanttelehealth visitsAI symptom checkeronline doctor visitdigital front doorvirtual care platformmedical AImedical chatbotpatient engagementpayer solutionsemployer health benefitssubscription healthcareEHR integrationmedical knowledge graph

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Doctronic Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Doctronic Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BMar 24, 2026
Series ASep 15, 2025
SeedApr 18, 2025

Key People

Founding team and executive leadership

Matt Pavelle

Co-founder And Co-CEO

Founding Team

Tom Foley

Director Of Clinical Operations (Doctronic), Chief Operating Officer (Doctronic Physician Group)

Executive Team

Doctronic Investors

Notable investors and investment history

InvestorRounds
Mantis Venture CapitalSeries B, Series A
Union Square VenturesSeries B, Series A, Seed
Davidovs Venture CapitalSeries B, Series A
Tusk Venture PartnersSeed, Series B, Series A
Abstract VenturesSeries B
HF0 ResidencySeed
Seven StarsSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Grew 53% QoQ, from 34 to 52 employees.

  • Mar 24, 2026

    $40M round completed.

Doctronic Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Doctronic Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Doctronic's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range52
Year Founded2023
Last FundingMar 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.